Biopharmaceutical implications of excipient variability on drug dissolution from immediate release products
first_published_at:July 16, 2020, midnight / date_published:July 16, 2020
Papers
-
16/07/2020 -
by
P. Zarmpi,
T. Flanagan,
E. Meehan,
J. Mann,
J. Østergaard,
N. Fotaki
Examining the influence of excipient variability on oral product performance from a biopharmaceutical perspective could be advantageous and facilitate the integration of excipients into Quality by Design (QbD) approaches. The …
